We believe that biosimilars are part of the solution to enable affordable healthcare.

Our unique protein production platform and analytical approach allows us to produce high quality biosimilar products efficiently and effectively to expand patient access to much needed therapies.

Additionally, we are one of the only companies focused on non-glycosylated biosimilars, creating a differentiated platform approach and competitive advantage. This focus allows us to ensure a robust pipeline of high-quality therapeutics, which will ensure we can expand patient access to life-changing therapies.

Learn more about Pfenex’s innovative approach to developing biosimilars here.

Bringing Biosimilars to Market:

Click here to download a PDF version of our Bringing Biosimilars To Market infographic.